Éric Levy

1.6k citations

34 papers · 1.1k indexed · h-index 17

Impact in

Dermatology top 2%
- Chemotherapy-related skin toxicity
Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Cancer Treatment and Pharmacology
- Viral-associated cancers and disorders

Papers in ⓘ

Oncology 18
- Cancer Immunotherapy and Biomarkers 7
- Cancer Treatment and Pharmacology 4
Cancer Research 11
- Cancer Genomics and Diagnostics 5
- Breast Cancer Treatment Studies 4

Co-authors: Stéphane Oudard (7 shared papers)Jean‐Marie Andrieu (6 shared papers)Eugéniu Banu (4 shared papers)Pascal Piedbois (3 shared papers)Éric Tartour (2 shared papers)Elias Haddad (3 shared papers)J.P. Le Bourgeois (3 shared papers)Helene Thygesen (2 shared papers)
Journals: Cancer Research (4 papers)Journal of Clinical Oncology (3 papers)Radiotherapy and Oncology (2 papers)Cancer (1 paper)Clinical Cancer Research (1 paper)
Partner nations: France United States United Kingdom

In The Last Decade

Éric Levy

32 papers receiving 1.0k citations

Peers

Countries citing papers authored by Éric Levy

Since Specialization

Citations

This map shows the geographic impact of Éric Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Éric Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Éric Levy more than expected).

Fields of papers citing papers by Éric Levy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Éric Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Éric Levy. The network helps show where Éric Levy may publish in the future.

Co-authors

The 25 scholars most cited alongside Éric Levy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Éric Levy Line = papers co-authored together Éric Levy links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	A Phase II Study of Tg4010 (Mva-Muc1-Il2) in Association with Chemotherapy in Patients with Stage III/IV Non-small Cell Lung Cancer Journal of Thoracic Oncology ·Rodryg Ramlau, Élisabeth Quoix, Janusz Rolski, Miklos Pless, H. Léna, Éric Levy, Maciej Krzakowski, Dagmar Hess, Éric Tartour, Marie‐Pierre Chenard, Jean‐Marc Limacher, Nadine Bizouarne, Bruce Acres, Céline Halluard, Thierry Velu	2008	162
2	Multicenter Study of a Frozen Glove to Prevent Docetaxel-Induced Onycholysis and Cutaneous Toxicity of the Hand Journal of Clinical Oncology ·Florian Scotté, Jean‐Marc Tourani, Eugéniu Banu, Michel Peyromaure, Éric Levy, Sandrine Marsan, E. Magherini, Elisabeth Fabre-Guillevin, Jean‐Marie Andrieu, Stéphane Oudard	2005	117
3	Long-term Results After Oncoplastic Surgery for Breast Cancer Annals of Surgery ·Krishna B. Clough, Raquel F. D. van la Parra, Helene Thygesen, Éric Levy, Elisabeth Russ, Najeeb Halabi, Isabelle Sarfati, Claude Nos	2017	101
4	Nrf2 Induces IL-17D to Mediate Tumor and Virus Surveillance Cell Reports ·Robert Saddawi‐Konefka, Ruth Seelige, Emilie Gross, Éric Levy, Stephen Searles, Allen Washington, Endi K. Santosa, Beichen Liu, Timothy E. O’Sullivan, Olivier Harismendy, Jack D. Bui	2016	96
5	A Fluorospot assay to detect single T lymphocytes simultaneously producing multiple cytokines Journal of Immunological Methods ·Agnès Gazagne, Emmanuel Claret, John Wijdenes, Hans Yssel, François Bousquet, Éric Levy, Philippe Vielh, Florian Scotté, Thierry Le Goupil, Wolf H. Fridman, Éric Tartour	2003	83
6	Landscape genomic analysis of candidate genes for climate adaptation in a California endemic oak, Quercus lobata American Journal of Botany ·Victoria L. Sork, Kevin Squire, Paul F. Gugger, Stephanie Steele, Éric Levy, Andrew J. Eckert	2016	82
7	Matched case‐control phase 2 study to evaluate the use of a frozen sock to prevent docetaxel‐induced onycholysis and cutaneous toxicity of the foot Cancer ·Florian Scotté, Eugéniu Banu, Jacques Médioni, Éric Levy, C. Ebenezer, Sandrine Marsan, Adela Banu, Jean Marc Tourani, Jean‐Marie Andrieu, Stéphane Oudard	2008	67
8	Radiotherapy in the management of epidemic Kaposi's sarcoma: a retrospective study of 643 cases Radiotherapy and Oncology ·Youlia Kirova, Ernest Bélembaogo, H. Frikha, Elias Haddad, É. Calitchi, Éric Levy, Pascal Piedbois, J.P. Le Bourgeois	1998	56
9	Radiotherapy in the management of epidemic Kaposi's sarcoma International Journal of Radiation OncologyBiologyPhysics ·Pascal Piedbois, H. Frikha, Laurent Martin, Éric Levy, Elias Haddad, J.P. Le Bourgeois	1994	47
10	Prediction of Immunotherapy Response in Melanoma through Combined Modeling of Neoantigen Burden and Immune-Related Resistance Mechanisms Clinical Cancer Research ·Charles W. Abbott, Sean M. Boyle, Rachel Marty Pyke, Lee McDaniel, Éric Levy, Fábio C. P. Navarro, Dattatreya Mellacheruvu, Simo V. Zhang, Mengyao Tan, Rose Santiago, Zeid M. Rusan, Pamela Milani, Gábor Bartha, Jason Harris, Rena McClory, M Snyder, Sekwon Jang, Richard Chen	2021	35
11	What is the real impact of bone pain on survival in patients with metastatic hormone‐refractory prostate cancer treated with docetaxel? British Journal of Urology ·Stéphane Oudard, Eugéniu Banu, Jacques Médioni, Florian Scotté, Adela Banu, Éric Levy, Johana Wasserman, Gabriel Kacsó, Jean‐Marie Andrieu	2009	27
12	FDG PET in patients with cancer of an unknown primary Nuclear Medicine Communications ·H. Kolesnikov-Gauthier, Éric Levy, Pascal Merlet, Julia Kirova, André Syrota, Philippe Carpentier, Michel Meignan, Pascal Piedbois	2005	25
13	Immune DNA signature of T-cell infiltration in breast tumor exomes Scientific Reports ·Éric Levy, Rachel Marty, Valentina Gárate Calderón, Brian Woo, Michelle T. Dow, Ricardo Armisén, Hannah Carter, Olivier Harismendy	2016	24
14	Oncological Safety of Oncoplastic Level II Mammoplasties After Neoadjuvant Chemotherapy for Large Breast Cancers: A Matched-Cohort Analysis Annals of Surgical Oncology ·Raquel F. D. van la Parra, Krishna B. Clough, Helene Thygesen, Éric Levy, B. Poulet, Isabelle Sarfati, Claude Nos	2021	20
15	A machine learning algorithm with subclonal sensitivity reveals widespread pan-cancer human leukocyte antigen loss of heterozygosity Nature Communications ·Rachel Marty Pyke, Dattatreya Mellacheruvu, Steven Dea, Charles W. Abbott, Lee McDaniel, Devayani P. Bhave, Simo V. Zhang, Éric Levy, Gábor Bartha, John West, M Snyder, Richard Chen, Sean Michael Boyle	2022	18
16	Radiotherapy in the management of mycosis fungoides: indications, results, prognosis. Twenty years experience Radiotherapy and Oncology ·Youlia Kirova, Youri Piedbois, Elias Haddad, Éric Levy, É. Calitchi, G. Marinello, J.P. Le Bourgeois	1999	18
17	Influence of ABCB1 polymorphisms and docetaxel pharmacokinetics on pathological response to neoadjuvant chemotherapy in breast cancer patients Breast Cancer Research and Treatment ·Pierre Lévy, Joseph Gligorov, Martine Antoine, Keyvan Rezaï, Éric Levy, Frédèric Selle, Pierre Saintigny, François Lokiec, D. Avenin, K. Beerblock, Jean-Pierre Lotz, Jean‐François Bernaudin, Anne Fajac	2013	17
18	MAGI: a Node.js web service for fast microRNA-Seq analysis in a GPU infrastructure Bioinformatics ·Ji Hoon Kim, Éric Levy, Alex Ferbrache, Petra Stepanowsky, Claudiu Farcas, Shuang Wang, Stefan F Brunner, Tyler Bath, Yuan Wu, Lucila Ohno‐Machado	2014	15
19	Whole genome sequencing of an African American family highlights toll like receptor 6 variants in Kawasaki disease susceptibility PLoS ONE ·Jihoon Kim, Chisato Shimizu, Stephen F. Kingsmore, Narayanan Veeraraghavan, Éric Levy, André Maurício Ribeiro dos Santos, Hai Yang, Jay Flatley, Long Hoàng, Martin L. Hibberd, Adriana H. Tremoulet, Olivier Harismendy, Lucila Ohno‐Machado, Jane C. Burns	2017	13
20	Serum PSA half‐life as a predictor of survival for hormone‐refractory prostate cancer patients: Modelization using a standardized set of response criteria The Prostate ·Eugéniu Banu, Adela Banu, Jacques Médioni, Éric Levy, Nicolas Thiounn, Arnaud Méjean, Jean‐Marie Andrieu, Stéphane Oudard	2007	10

About Éric Levy

Éric Levy is a scholar working on Oncology, Cancer Research, Pathology and Forensic Medicine, Molecular Biology and Immunology, having authored 34 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), Immunotherapy and Immune Responses (6 papers), Cancer Genomics and Diagnostics (5 papers), Lymphoma Diagnosis and Treatment (5 papers), Cancer Treatment and Pharmacology (4 papers), Breast Cancer Treatment Studies (4 papers), Chemotherapy-related skin toxicity (3 papers) and Immune Cell Function and Interaction (3 papers). The work is most often cited by research in Dermatology (203 citations), Oncology (509 citations), Immunology (279 citations), Cancer Research (156 citations) and Pathology and Forensic Medicine (130 citations). Éric Levy has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Stéphane Oudard, Jean‐Marie Andrieu, Eugéniu Banu, Pascal Piedbois, Éric Tartour, Elias Haddad, J.P. Le Bourgeois, Helene Thygesen, Isabelle Sarfati and H. Frikha. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Radiotherapy and Oncology, Cancer and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact